Accès gratuit
| Numéro |
Med Sci (Paris)
Volume 29, Numéro 11, Novembre 2013
|
|
|---|---|---|
| Page(s) | 940 - 942 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/20132911003 | |
| Publié en ligne | 20 novembre 2013 | |
- Passegué E, Wagers AJ, Giuriato S, et al. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med 2005 ; 202 : 1599–1611. [CrossRef] [PubMed] [Google Scholar]
- Wilson A, Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 2006 ; 6 : 93–106. [CrossRef] [PubMed] [Google Scholar]
- Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002 ; 30 : 973–981. [CrossRef] [PubMed] [Google Scholar]
- Fortunel NO, Hatzfeld A, Hatzfeld JA. Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis. Blood 2000 ; 96 : 2022–2036. [PubMed] [Google Scholar]
- Scandura JM, Boccuni P, Massagué J, Nimer SD. Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc Natl Acad Sci USA 2004 ; 101 : 15231–15236. [CrossRef] [Google Scholar]
- Levéen P, Larsson J, Ehinger M, et al. Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood 2002 ; 100 : 560–568. [CrossRef] [PubMed] [Google Scholar]
- Yaswen L, Kulkarni AB, Fredrickson T, et al. Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. Blood 1996 ; 87 : 1439–1445. [PubMed] [Google Scholar]
- Matsumoto A, Takeishi S, Kanie T, et al. p57 is required for quiescence and maintenance of adult hematopoietic stem cells. Cell Stem Cell 2011 ; 9 : 262–271. [CrossRef] [PubMed] [Google Scholar]
- Brenet F, Kermani P, Spektor R, et al. TGF-beta restores hematopoietic homeostasis after myelosuppressive chemotherapy. J Exp Med 2013 ; 210 : 623–639. [CrossRef] [PubMed] [Google Scholar]
- Yan Y, Frisén J, Lee MH, et al. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev 1997 ; 11 : 973–983. [CrossRef] [PubMed] [Google Scholar]
- Lyman GHJ. Impact of chemotherapy dose intensity on cancer patient outcomes. Natl Compr Canc Netw 2009 ; 7 : 99–108. [Google Scholar]
- Yingling JM, Blanchard KL, Sawyer JS. Development of TGF-beta signalling inhibitors for cancer therapy. Nat Rev Drug Discov 2004 ; 3 : 1011–1022. [CrossRef] [PubMed] [Google Scholar]
- Muraoka RS, Dumont N, Ritter CA, et al. Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. J Clin Invest 2002 ; 109 : 1551–1559. [PubMed] [Google Scholar]
- Lataillade JJ, Brunet de la Grange P, Uzan G, Le Bousse-Kerdilès MC. Les cellules souches ont-elles l’âge de leur niche ? Med Sci (Paris) 2010 ; 26 : 582–585. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.